[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355623-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355623-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","proximity-mapping-of-the-er-proteome-reveals-metastasis-specific-candidate-biomarkers-in-breast-cancer-cell-lines-abstract","Proximity Mapping of the ER Proteome Reveals Metastasis-specific Candidate Biomarkers in Breast Cancer Cell Lines - Abstract","","Breast cancer is the most commonly diagnosed cancer among women, yet existing biomarkers often lack sufficient specificity and sensitivity. The endoplasmic reticulum (ER) is essential for protein folding, post-translational modification, and lipid metabolism, and ER alterations correlate with tumor progression. This study mapped ER proteome changes linked to invasiveness and identified novel metastasis-related candidate biomarkers in MCF-7 and MDA-MB-231 cells.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/proximity-mapping-of-the-er-proteome-reveals-metastasis-specific-candidate-biomarkers-in-breast-cancer-cell-lines-abstract/355623/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/proximity-mapping-of-the-er-proteome-reveals-metastasis-specific-candidate-biomarkers-in-breast-cancer-cell-lines-abstract/355623.png","ImageObject",300,407,{"name":42,"@type":43},"วิน","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address about breast cancer biomarkers?","Question",{"text":63,"@type":64},"Current biomarkers have insufficient specificity and sensitivity for early detection and therapy. The study targets the need for more novel, robust markers.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were ER proteome differences analyzed between the two breast cancer cell lines?",{"text":68,"@type":64},"ER proteomes of non-invasive MCF-7 and invasive MDA-MB-231 cells were compared using ER-targeted TurboID proximity labeling followed by LC–MS/MS, with bioinformatic analyses for functional links to invasion and metastasis.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key findings regarding ER proteins and metastasis?",{"text":72,"@type":64},"A total of 2,079 proteins were identified, including 1,378 ER proteins, and more than four hundred ER-resident or associated proteins were differentially regulated in invasive cells. The study also identified 36 ER-associated proteins as new candidate links to breast cancer.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355623,1790142313,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":118,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":104,"preview_page_count":33,"preview_urls":144},2336475104736,"https://ap-avatar.wpscdn.com/avatar/22000c4c5e0e5b17e70?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786591360781797222","doi: 10.21873/cgp.20586  \nProximity Mapping ofthe ER Proteome Reveals Metastasisspecific Candidate Biomarkers in Breast Cancer Cell Lines  \nMEHMET SARIHAN, ELIFCAN KOCYIGIT, MURAT KASAP and GURLER AKPINAR  \nProteomics Laboratory, Department of Medical Biology, Faculty of Medicine, Kocaeli University, Kocaeli, Türkiye  \nAbstract  \nBackground/Aim: Breast cancer is the most frequently diagnosed cancer among women. While biomarkers are critical for early detection and therapy, current markers lack sufficient specificity and sensitivity. The endoplasmic reticulum (ER) plays a central role in protein folding, post-translational modification, and lipid metabolism, and its alterations are linked to tumor progression. This study aimed to map ER proteome changes associated with breast cancer invasiveness and identify novel candidate biomarkers.  \nMaterials and Methods: We compared the ER proteomes of non-invasive MCF-7 and invasive MDA-MB-231 breast cancer cell lines using an ER-targeted TurboID proximity labelling approach, followed by LC–MS/MS analysis. Bioinformatic analyses were performed to determine functional associations and differential expression related to invasion and metastasis for the candidate biomarkers.  \nResults: A total of 2,079 proteins were identified, including 1,378 ER proteins. Analysis revealed that more than four hundred ER-resident or associated proteins were differentially regulated in invasive MDA-MB-231, many of which were linked to invasion and metastasis. Upregulated proteins were involved in cellular localization, ECM remodeling, cell mobility, adhesion, vesicle trafficking, and ER stress, whereas downregulated proteins were primarily associated with energy metabolism. Additionally, in this study, 36 ER-associated proteins were identified for the first time as candidates linked to breast cancer, highlighting their potential as novel biomarkers and therapeutic targets. Conclusion: ER-targeted TurboID proximity labelling effectively maps the proteomic landscape of breast cancer cells, revealing functional adaptations that support invasive and metastatic phenotypes. Notably, 36 ER proteins were identified as novel candidates not previously linked to breast cancer, highlighting new potential biomarkers and therapeutic targets. These findings provide valuable insights into ER proteome remodeling, offering avenues for understanding breast cancer progression and strategies to prevent metastasis.  \nKeywords: Breast cancer, ER-proteome, biomarker, invasion and metastasis, biotinylation.  \n✉ Mehmet Sarihan, Department of Medical Biology, Medical Faculty of Kocaeli University, 41380 Umuttepe, Kocaeli, Türkiye.  \nTel: +90 5318475929, [e-mail:](e-mail: mehmet.sarihan@kocaeli.edu.tr)[ mehmet.sarihan@kocaeli.edu.tr](e-mail: mehmet.sarihan@kocaeli.edu.tr)  \nReceived February 12, 2026 | Revised March 14, 2026 | Accepted March 23, 2026  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n©2026 The Author(s) . Anticancer Research is published by the International Institute of Anticancer Research.  \nIntroduction  \nCancer remains one of the leading causes of morbidity and mortality worldwide, despite extensive efforts and scientific advancements. According to 2022 statistical data, nearly twenty million new cancer cases were reported globally (1). Among all cancer types in women, breast cancer has the highest incidence and approximately 2.3 million new cases are diagnosed each year. It ranks after lung, colorectal and liver cancersin mortality, but remains the leading cause of cancer-related deaths among women, with an estimated 685,000 deaths worldwide in 2020 (1). Breast cancer incidence is highest in high-income regions such as Northern America, Western Europeanditis lowest in parts of Asia and Africa (2, 3). Conversely, despite a lower incidence, low-and middle-income re","cbCaihMMC5VBpGUb","https://ap.wps.com/l/cbCaihMMC5VBpGUb","pdf",9461483,"English","# Abstract\n## Background/Aim\n## Materials and Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What problem does the study address about breast cancer biomarkers?\",\"answer\":\"Current biomarkers have insufficient specificity and sensitivity for early detection and therapy. The study targets the need for more novel, robust markers.\"},{\"question\":\"How were ER proteome differences analyzed between the two breast cancer cell lines?\",\"answer\":\"ER proteomes of non-invasive MCF-7 and invasive MDA-MB-231 cells were compared using ER-targeted TurboID proximity labeling followed by LC–MS/MS, with bioinformatic analyses for functional links to invasion and metastasis.\"},{\"question\":\"What were the key findings regarding ER proteins and metastasis?\",\"answer\":\"A total of 2,079 proteins were identified, including 1,378 ER proteins, and more than four hundred ER-resident or associated proteins were differentially regulated in invasive cells. The study also identified 36 ER-associated proteins as new candidate links to breast cancer.\"}]","Proximity Mapping of the ER Proteome Reveals Metastasis-specific Candidate Biomarkers in Breast Cancer Cell Lines - Abstract | PDF",1790120182,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b446addf535bdb224fb3423c447318d.webp",983,1310,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14b988766a81a1a3493b95e9238cdaf7.webp",982,1309,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fa977592ade59c8c74eea47e63076796.webp",981,1308,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ebd0a1c35d097da612cc44541e79e740.webp",980,1306]